CORT
CORCEPT THERAPEUTICS INC
Key Financials
Net Income
$99.7M
↓ 29.4%
Operating Income
$44.8M
↓ 67.3%
Gross Profit
$84.5M
↓ 0.7%
Revenue
$761.4M
↑ 12.8%
EPS (Diluted)
$0.82
↓ 33.3%
Total Liabilities
$188.8M
↑ 17.3%
Total Assets
$836.7M
↓ 0.5%
Shareholders' Equity
$647.8M
↓ 4.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 144 | 10/1/2026 | View on SEC |
| 4 | 9/28/2026 | View on SEC |
| 8-K | 9/23/2026 | View on SEC |
| 4 | 9/18/2026 | View on SEC |
| 4 | 9/18/2026 | View on SEC |
| 4 | 9/16/2026 | View on SEC |
| 4 | 9/16/2026 | View on SEC |
| 144 | 9/15/2026 | View on SEC |
| 144 | 9/14/2026 | View on SEC |
| 4 | 9/3/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CORT |
| Company Name | CORCEPT THERAPEUTICS INC |
| CIK | 1088856 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 650.688.8803 |